Postoperative radiotherapy for breast cancer UK consensus statements
Date: 2016
The Postoperative radiotherapy for breast cancer: UK consensus statements were developed by members of the oncology community, including professional groups, commissioners and patients. They state the expected standard for breast radiotherapy across the UK, covering cardiac sparing, breast boost radiotherapy, safe omission of radiotherapy, internal mammary chain (IMC) radiotherapy, hypofractionation, axillary management of sentinel lymph node-positive disease and partial breast radiotherapy. The statements on hypofractionation should be read in conjunction with the updated consensus statements published in May 2021.
This is an opportunity to clearly state the expected standard for breast radiotherapy across the UK to make sure that patients receive equal treatment regardless of postcode.
The document includes the consensus statements alongside details of the process and evidence used to reach them.
